Bioventus Inc. Class A Common Stock BVS
HEALTHCARE · MEDICAL DEVICESi
Market dataready · fetched 2026-11-11T14:51:37.645Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:51:32.76434283Z
FundamentalsAlpha Vantage · ready · quarter 2026-09-30 · fetched 2026-11-11T14:51:36.415698+00:00
Bioventus Inc. Class A Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 8.62 | 240.7% | 28.5% | |||
| 25Δ | 21.05 | 399.5% | 95.9% | 9.22 | 243.4% | 25.1% |
| 30Δ | 20.08 | 426.0% | 89.3% | 9.81 | 246.1% | 21.6% |
| 35Δ | 15.98 | 336.9% | 52.8% | 10.16 | 235.3% | 19.3% |
| 40Δ | 13.97 | 277.0% | 34.9% | 10.39 | 218.4% | 17.4% |
| 45Δ | 12.50 | 228.4% | 22.0% | 10.62 | 201.5% | 15.6% |
| 50Δ | 12.13 | 209.1% | 19.1% | 10.85 | 184.6% | 13.7% |
| 55Δ | 11.76 | 189.8% | 16.1% | 11.08 | 167.7% | 11.9% |
| 60Δ | 11.39 | 170.6% | 13.2% | 11.31 | 150.8% | 10.1% |
| 65Δ | 11.02 | 151.3% | 10.2% | 11.54 | 133.9% | 8.2% |
| 70Δ | 10.65 | 132.0% | 7.3% | 11.77 | 117.1% | 6.4% |
| 75Δ | 10.28 | 112.7% | 4.3% | 12.00 | 100.2% | 4.6% |
| 80Δ | 12.23 | 83.3% | 2.7% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 8.62
- IV
- 240.7%
- B/E move
- 28.5%
25Δ
- Pseudo strike
- 21.05
- IV
- 399.5%
- B/E move
- 95.9%
- Pseudo strike
- 9.22
- IV
- 243.4%
- B/E move
- 25.1%
30Δ
- Pseudo strike
- 20.08
- IV
- 426.0%
- B/E move
- 89.3%
- Pseudo strike
- 9.81
- IV
- 246.1%
- B/E move
- 21.6%
35Δ
- Pseudo strike
- 15.98
- IV
- 336.9%
- B/E move
- 52.8%
- Pseudo strike
- 10.16
- IV
- 235.3%
- B/E move
- 19.3%
40Δ
- Pseudo strike
- 13.97
- IV
- 277.0%
- B/E move
- 34.9%
- Pseudo strike
- 10.39
- IV
- 218.4%
- B/E move
- 17.4%
45Δ
- Pseudo strike
- 12.50
- IV
- 228.4%
- B/E move
- 22.0%
- Pseudo strike
- 10.62
- IV
- 201.5%
- B/E move
- 15.6%
50Δ
- Pseudo strike
- 12.13
- IV
- 209.1%
- B/E move
- 19.1%
- Pseudo strike
- 10.85
- IV
- 184.6%
- B/E move
- 13.7%
55Δ
- Pseudo strike
- 11.76
- IV
- 189.8%
- B/E move
- 16.1%
- Pseudo strike
- 11.08
- IV
- 167.7%
- B/E move
- 11.9%
60Δ
- Pseudo strike
- 11.39
- IV
- 170.6%
- B/E move
- 13.2%
- Pseudo strike
- 11.31
- IV
- 150.8%
- B/E move
- 10.1%
65Δ
- Pseudo strike
- 11.02
- IV
- 151.3%
- B/E move
- 10.2%
- Pseudo strike
- 11.54
- IV
- 133.9%
- B/E move
- 8.2%
70Δ
- Pseudo strike
- 10.65
- IV
- 132.0%
- B/E move
- 7.3%
- Pseudo strike
- 11.77
- IV
- 117.1%
- B/E move
- 6.4%
75Δ
- Pseudo strike
- 10.28
- IV
- 112.7%
- B/E move
- 4.3%
- Pseudo strike
- 12.00
- IV
- 100.2%
- B/E move
- 4.6%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 12.23
- IV
- 83.3%
- B/E move
- 2.7%
Options history
Table
| Date | IV (%) |
|---|---|
| 89.00% | |
| 62.56% | |
| 59.58% | |
| 73.23% | |
| 62.02% | |
| 73.57% | |
| 83.20% | |
| 74.80% | |
| 70.94% | |
| 70.81% | |
| 66.21% | |
| 75.19% | |
| 80.41% | |
| 68.19% | |
| 78.51% | |
| 70.13% | |
| 69.17% |
Medical Devices
BWAY
Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company…
More →CATX
Perspective Therapeutics Inc. (CATX) is a pioneering biotechnology firm focused on revolutionizing cancer care through the development of innovative radiopharmaceuticals.…
More →CBLL
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company is headquartered in…
More →CERS
Cerus Corporation, a biomedical products company, is focused on developing and commercializing the INTERCEPT Blood System to improve blood safety. The company is headquartered in…
More →CLPT
ClearPoint Neuro, Inc. is a medical device company primarily in the United States. The company is headquartered in Irvine, California.
More →CNMD
CONMED Corporation, a medical technology company, develops, manufactures and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company…
More →